BackStatera BioPharma Overview

Statera BioPharma Cost of Revenue

Cost of Revenue analysis for STAB.

Quarterly Cost of Revenue

$169354.00
↑ 46.09% YoY

As of Sep 30, 2022

Annual Cost of Revenue (TTM)

$1.10M
↑ 845.72% YoY

Trailing 12 months ending Sep 30, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin